European VitreoRetinal Society a certain philosophy

Poster Gavin Tan Introduction: Choroidal neovascularization (CNV) is rare but important cause of visual impairment in children. It is often idiopathic or secondary to inflammation, optic nerve head abnormalities or retinal dystrophies. There is a lack of clinical trials assessing the treatment of CNV in children. Methods: A 11-year-old boy with no past medical or ocular history presented with 3 months duration of reduced vision in his...

Salim Ben Yahia, Bechir Jelliti, Rim Kahloun, Rim Ghrissi, Salah Jenzeri, Moncef Khairallah (Monastir, Tunisia) Advantages: To manage inflammatory choroidal neovascularization (CNV) with intravitreal injection of bevacizumab, since conventional therapeutic options, including laser photocoagulation, surgery, corticosteroids, and verteporfin therapy, have potential limitations and are associated with a high rate of recurrences. Methods:...

http://www.evrs.eu/medias/2008/congress/Treatment-of-Non-AMD-(Myopic,-Inflammatory,-Angioid-Streak…)-Subfoveal-Choroidal-New-Vessels-with-Intravitreal-Anti-VEGF-Instead-of-Photodynamic-Therapy.flv Catherine Favard, Martine Mauget-Faysse Advantages: Intravitreal anti-VEGF therapy appears very effective to treat AMD choroidal new vessels and shows no choroidal ischemia and does not induce VEGF upregulation when compared to photodynamic...

Myriam Lucia Hernandez-Rojas, MD (Mexico City, Jose Dalma- Weiszhausz, MD (MexicoCity, Mexico), Hugo Quiroz- Mercado, MD (Mexico City, Mexico), Jans Fromow-Guerra, MD, PhD (Mexico City, Mexico), Griselda Alvarez-Rivera, MD (Mexico City, Mexico), Maura Abraham-Marin, MD (Mexico City, Mexico), Adriana Solis-Vivanco, MD (Mexico City, Mexico), Elizabeth Reyna-Castelan, MD (Mexico City, Mexico), Jose Luis Guerrero-Naranjo,MD (Mexico City,...

http://www.evrs.eu/medias/2006/congress/The-Effects-of-Combined-Inhibition-of-Platelet-derived-Growth- Factor-(PDGF-B)-and-VEGF-A-Signaling-in-Murine-Models-of-Ocular-Neovascularization.swf Anthony P. Adamis, MD (New York, NY),* David R. Guyer, MD (New York, NY)* PURPOSE: While the inhibition of VEGF-A signaling can prevent new blood vessel growth in cancer and ocular pathologies, more mature vessels appear to be less susceptible. Since...

http://www.evrs.eu/medias/2006/congress/Intravitreal-Bevacizumab-as-Isolated-First-Line-Therapy-in-Patients-with-New-Untreated-Choroidal-Neovascular-Membranes.swf Alay S Banker, MD (Ahmedabad, India), Marisa Flores-Aguilar, MD (Tijuana, Mexico), J. Fernando Arevalo, MD, FACS (Caracas, Venezuela) PURPOSE: To determine results of intravitreal bevacizumab in patients with choroidal neovascular membranes (CNVMs) of different types and...